middle.news
Firebrick Pharma Advances Southeast Asia Expansion with Indonesia Approval and $1.5M Raise
6:04pm on Tuesday 21st of April, 2026 AEST
•
Healthcare
Read Story
Firebrick Pharma Advances Southeast Asia Expansion with Indonesia Approval and $1.5M Raise
6:04pm on Tuesday 21st of April, 2026 AEST
Key Points
Nasodine Nasal Spray approved in Indonesia, Southeast Asia's largest market
Nasodine Throat Spray launched in Singapore and Fiji with strong initial demand
New North American and business development appointments to drive global growth
$1.5 million raised via private placement to secure 12-month funding runway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Firebrick Pharma (ASX:FRE)
OPEN ARTICLE